The nation of Zimbabwe has declined a significant US health deal valued at $367m (272 million pounds) over five years due to Washington's request for sensitive biological samples.
The decision became public following a official document dated December was leaked, revealing that President Emmerson Mnangagwa believed the deal was "lopsided".
An official spokesperson has since explained that the United States was demanding access to genetic material for scientific study and profit while refused to share the resulting advantages from future medical innovations.
"We must now begin the challenging and unfortunate process of scaling back our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had donated more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has called for further negotiations to secure a deal acceptable to all parties so the nation's vital HIV treatment initiative can proceed.
Wider Implications
This rejection comes after a similar case in neighbouring Kenya, where a high court blocked a related health funding agreement after concerns were raised about the security of citizens' health data.
Since resuming the presidency last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
The agency had overseen aid for the American government, but Trump stated its expenditure was "wasteful" and his administration was seeking government-to-government agreements to boost transparency and accountability.
As per statements, Sixteen nations in Africa have so far agreed to these new agreements, constituting over $18.3bn in committed funds.
Specifics of the Rejected Agreement
The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this cooperation could have provided immense benefits for Zimbabwean communities, particularly the 1.2 million currently on HIV treatment via US-supported initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".
"Zimbabwe was being asked to provide its genetic material and health information for a long time, with no equivalent assurance of access to any medical innovations – like new medicines or tests – that might result from that shared data," Mangwana explained.
"Effectively, our country would provide the raw materials for medical research with no assurance that the resulting innovations would be available to our people should a new disease outbreak emerge."
Sovereignty and International Frameworks
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were upending frameworks previously set up via the international organization.
Mangwana cited its Pandemic Benefit-Sharing framework designed to deal with future global health emergencies.
"This mechanism is intended to ensure that when a country provides its samples, the benefits – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the funds to create them."
The government's concerns over the US deal "should not be misconstrued as anti-American sentiment," he added.
"We are open to ongoing discussions with our American counterparts on how subsequent co-operation could be designed in a manner that honours the independence and interests of each country."
Medical Community Reaction
A leading public health body said it understood the government's concerns, but recommended that negotiations need to persist considering much of the country's Aids initiatives were funded by external financing.
"Where technical issues arise, such as those relating to data governance or implementation frameworks, these can often be resolved via detailed discussion and mutually agreed protections," the group added.
The halted deal emphasises the continuing challenges between receiving vital foreign assistance and safeguarding national sovereignty in an ever more data-driven world.